Alan B. Lancz & Associates’s Tecogen Inc TGEN Stock Holding History

Alan B. Lancz & Associates’s Portfolio TGEN Stock Details TGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,404	Closed	-$12K	–	161
2021 Q4	$12K	Buy	+10,404	New	+$12K	0.01%	147

Other funds holding TGEN

HIM

Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return

Alan B. Lancz & Associates's TGEN Position: Q1 2022 in Review

Alan B. Lancz & Associates sold out of Tecogen Inc (TGEN) in Q1 2022, closing a stake of 10,404 shares — an estimated $12K sold.

Alan B. Lancz & Associates first reported a position in TGEN in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 1 fund tracked by Wall St. Rank holds TGEN as of Q1 2022.

Alan B. Lancz & Associates reported no remaining Tecogen Inc position as of Q1 2022 after selling out during the quarter.
Alan B. Lancz & Associates sold 10,404 Tecogen Inc shares in Q1 2022, an estimated $12K.
Alan B. Lancz & Associates first reported a position in Tecogen Inc in Q4 2021 and held it in 1 quarter.
Alan B. Lancz & Associates's Tecogen Inc position peaked at $12K in Q4 2021.
1 fund tracked by Wall St. Rank held Tecogen Inc as of Q1 2022.

Based on Alan B. Lancz & Associates's 13F filing for Q1 2022, filed 12 May 2022.